Literature DB >> 27539578

Novel Homozygous Missense Mutation in SPG20 Gene Results in Troyer Syndrome Associated with Mitochondrial Cytochrome c Oxidase Deficiency.

Ronen Spiegel1,2,3, Devorah Soiferman4,5, Avraham Shaag4, Stavit Shalev6,7, Orly Elpeleg4, Ann Saada4,5.   

Abstract

Troyer syndrome is an autosomal recessive form of hereditary spastic paraplegia (HSP) caused by deleterious mutations in the SPG20 gene. Although the disease is associated with a loss of function mechanism of spartin, the protein encoded by SPG20, the precise pathogenesis is yet to be elucidated. Recent data indicated an important role for spartin in both mitochondrial maintenance and function. Here we report a child presenting with progressive spastic paraparesis, generalized muscle weakness, dysarthria, impaired growth, and severe isolated decrease in muscle cytochrome c oxidase (COX) activity. Whole exome sequencing identified the homozygous c.988A>G variant in SPG20 gene (p.Met330Val) resulting in almost complete loss of spartin in skeletal muscle. Further analyses demonstrated significant tissue specific reduction of COX 4, a nuclear encoded subunit of COX, in muscle suggesting a role for spartin in proper mitochondrial respiratory chain function mediated by COX activity. Our findings need to be verified in other Troyer syndrome patients in order to classify it as a form of HSP caused by mitochondrial dysfunction.

Entities:  

Keywords:  Cytochrome c oxidase; Hereditary spastic paraplegia; Mitochondria; Oxidative phosphorylation; SPG20; Troyer syndrome

Year:  2016        PMID: 27539578      PMCID: PMC5413448          DOI: 10.1007/8904_2016_580

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  21 in total

1.  The hereditary spastic paraplegia protein spartin localises to mitochondria.

Authors:  JianPing Lu; Faiza Rashid; Paula C Byrne
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

2.  Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1.

Authors:  Lukas Stiburek; Katerina Vesela; Hana Hansikova; Petr Pecina; Marketa Tesarova; Leona Cerna; Josef Houstek; Jiri Zeman
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking.

Authors:  Joanna C Bakowska; Henri Jupille; Parvin Fatheddin; Rosa Puertollano; Craig Blackstone
Journal:  Mol Biol Cell       Date:  2007-03-01       Impact factor: 4.138

4.  Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia.

Authors:  Alexander Lossos; Claudia Stümpfig; Giovanni Stevanin; Marion Gaussen; Bat-El Zimmerman; Emeline Mundwiller; Moriya Asulin; Liat Chamma; Ruth Sheffer; Adel Misk; Shlomo Dotan; John M Gomori; Penina Ponger; Alexis Brice; Israela Lerer; Vardiella Meiner; Roland Lill
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

5.  SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia.

Authors:  Heema Patel; Harold Cross; Christos Proukakis; Ruth Hershberger; Peer Bork; Francesca D Ciccarelli; Michael A Patton; Victor A McKusick; Andrew H Crosby
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

6.  The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo.

Authors:  Peter Bross; Søren Naundrup; Jakob Hansen; Marit Nyholm Nielsen; Jane Hvarregaard Christensen; Mogens Kruhøffer; Johan Palmfeldt; Thomas Juhl Corydon; Niels Gregersen; Debbie Ang; Costa Georgopoulos; Kåre Lehmann Nielsen
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

7.  Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism?

Authors:  Joanna C Bakowska; Heng Wang; Baozhong Xin; Charlotte J Sumner; Craig Blackstone
Journal:  Arch Neurol       Date:  2008-04

8.  A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover.

Authors:  Scott W Eastman; Mina Yassaee; Paul D Bieniasz
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

9.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia.

Authors:  Luigia Atorino; Laura Silvestri; Mirko Koppen; Laura Cassina; Andrea Ballabio; Roberto Marconi; Thomas Langer; Giorgio Casari
Journal:  J Cell Biol       Date:  2003-11-17       Impact factor: 10.539

10.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.

Authors:  Anke Hensiek; Stephen Kirker; Evan Reid
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

View more
  7 in total

Review 1.  The role of TGF-β superfamily signaling in neurological disorders.

Authors:  Risa Kashima; Akiko Hata
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

2.  Novel SPG20 mutation in an extended family with Troyer syndrome.

Authors:  S Bizzari; A R Hamzeh; P Nair; M Mohamed; F Saif; G Aithala; M T Al-Ali; F Bastaki
Journal:  Metab Brain Dis       Date:  2017-09-05       Impact factor: 3.584

3.  Methylation Heterogeneity and Gene Expression of SPG20 in Solid Tumors.

Authors:  Vincenza Ylenia Cusenza; Luca Braglia; Raffaele Frazzi
Journal:  Genes (Basel)       Date:  2022-05-12       Impact factor: 4.141

4.  Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin.

Authors:  Julia Ring; Patrick Rockenfeller; Claudia Abraham; Jelena Tadic; Michael Poglitsch; Katherina Schimmel; Julia Westermayer; Simon Schauer; Bettina Achleitner; Christa Schimpel; Barbara Moitzi; Gerald N Rechberger; Stephan J Sigrist; Didac Carmona-Gutierrez; Guido Kroemer; Sabrina Büttner; Tobias Eisenberg; Frank Madeo
Journal:  Microb Cell       Date:  2017-11-30

5.  The Relationship between Mitochondrial Respiratory Chain Activities in Muscle and Metabolites in Plasma and Urine: A Retrospective Study.

Authors:  Corinne Alban; Elena Fatale; Abed Joulani; Polina Ilin; Ann Saada
Journal:  J Clin Med       Date:  2017-03-10       Impact factor: 4.241

6.  KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.

Authors:  Raffaele Frazzi; Vincenza Ylenia Cusenza; Mariaelena Pistoni; Laura Canovi; Luciano Cascione; Francesco Bertoni; Francesco Merli
Journal:  Oncol Rep       Date:  2021-11-09       Impact factor: 3.906

7.  SPG20 mutation in three siblings with familial hereditary spastic paraplegia.

Authors:  Leila Dardour; Filip Roelens; Valerie Race; Erika Souche; Maureen Holvoet; Koen Devriendt
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.